| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2022 , Vol 60 , Num 4
Formulation and evaluation of transdermal ultradeformable vesicles of aspirin
1 Department of Pharmaceutics, Krupanidhi College of Pharmacy, Chikkabellandur, Carmelram (PO), Bengaluru, Karnataka, India2 Department of Pharmaceutics, Krupanidhi College of Pharmacy, Chikkabellandur, Carmelram, Varthur, Hobli, Bangalore, 560035, Karnataka, India
DOI : 10.23893/1307-2080.APS6025 Viewed : 8830 - Downloaded : 2250 Transfersomes are incredibly elastic and deformable vesicles composed of phospholipids and edge activators. This study proposed aspirin-loaded transfersomes for transdermal administration to prevent gastrointestinal side effects, boost drug permeation rate, and extend drug action. The formulations were prepared via the thin-film hydration method using soy lecithin as a vesicle forming agent and tween 80 as an edge activator. The formulation trials were optimized by "Custom design" JMP SW13. The optimum formulation yielded a vesicle size of 74.4 nm, a zeta potential of -27.4 mV, and a % entrapment efficiency of 90.5%±0.25 with a drug release of 88.65 %±0.34. A 1% carbopol gel incorporated the optimum formula. The homogeneous gel had a drug content of 95.8±1.5 %, a viscosity of 1762cP, a pH of 5.74±0.78, and % a drug release of 85.5%±0.85. The study concluded that transdermal transfersomes would be a promising approach to treating angina. Keywords : Transfersomes, Ultra-deformable, Vesicles, Phospholipids, Optimization